Recida Therapeutics is Biotechnology in United States that focus on developer business. Founded in 2016. They cover business area such as developer, antibiotic drug, novel therapeutic, serious antibiotic-resistant infection, novel-class antibiotic, multi-drug resistant gram-negative bacteria, patient, potentially deadly pathogen.
2016
( 8 years old in 2024 )
Developer
-
70 Willow Road
Suite 200
Menlo Park, CA 94025
United States
Private
developerantibiotic drugnovel therapeuticserious antibiotic-resistant infectionnovel-class antibioticmulti-drug resistant gram-negative bacteriapatientpotentially deadly pathogen
* We use standard office opening hours in near Recida Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Recida Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Recida Therapeutics business is focusing on Developer.
Recida Therapeutics headquarter office and corporate office address is located in 70 Willow Road Suite 200 Menlo Park, CA 94025 United States.
Recida Therapeutics was founded in United States.
In 2024, Recida Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Recida Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
